In the News

Spinal implant shown to reduce chance of disc reherniations – Becker’s Spine

A spine device that received FDA premarket approval has been shown to reduce the chance of disc herniations in patients who have already herniated a disc, The News Times reported July 13. The Barricaid implant, developed by Intrinsic Therapeutics, has a polyester flap to close the tear in the disc and a jagged anchor that inserts into […]

Read more

Danbury doctor completes groundbreaking back surgery, first in CT

On a Thursday in mid-June, Dr. David Bomback scrubbed-in for surgery and prepared to do what no Connecticut surgeon had done before. He was performing a groundbreaking lower-back surgery on 36-year-old Joe Esposito, a physical therapist from Sandy Hook, to insert a new device that could help prevent Esposito’s spinal disk from re-herniating. The lower-back […]

Read more

VA Adds C9757 Code to 2021 Fee Schedule

Intrinsic Therapeutics is proud to announce that the US Veterans Administration (VA) has officially added the (Barricaid Implantation) HCPCS code C9757 to their 2021 national outpatient fee schedule – effective January 1, 2021.¹  The VA is the 2nd largest government-funded health insurance organization in the U.S. with approximately 9 million covered lives. The Barricaid, a […]

Read more

A Level IA Expert Review and Meta-Analysis Provides Support for the Adoption of Barricaid in Well-Selected Patients Undergoing Lumbar Discectomy for Lumbar Disc Herniation

The importance of a cost-effective treatment option for patients with large annular defects is underscored by a recently published Level IA expert review and meta-analysis of four comparative studies (n=801 patients) including two randomized controlled trials involving more than 600 patients. In this review, the authors (L Miller, R Todd Allen, B Duhon, K Radcliff) […]

Read more

Surgeons and Spine Societies Increase Patient Access to Barricaid® for Discectomy Surgery Following Recent Coding Successes and Recognition in Updated Guidelines

Intrinsic Therapeutics Offers Virtual and Hands-On Training Sessions as Elective Surgeries Resume – via PR Newswire WOBURN, Mass., June 2, 2020 – Intrinsic Therapeutics, Inc., a medical device company focused on delivering safe treatments to improve surgical efficacy, today announced growing enthusiasm among physicians for its Barricaid technology, which manages lumbar disc herniation.  While elective […]

Read more

COVID-19 Company Update

“The measure of intelligence is the ability to change.” ― Albert Einstein. While this unprecedented time has forced us all to make changes and sacrifices, the Intrinsic team is using the time to learn and adopt innovative ways to educate and train the medical and patient communities on the impact Barricaid can have in managing lumbar […]

Read more

Annular Closure a Key Topic in latest Int Journal of Spine Surgery

Barricaid and the topic of annular closure for herniated disc patients feature in two articles in the most recent issue by IJSS, the International Journal of Spine Surgery. This journal is the official publication of ISASS, the International Society for the Advancement of Spine Surgery. ISASS is among the largest societies of spine surgeons, and […]

Read more

Recap of a successful inaugural U.S. Disc Collective Meeting

New York NY, January 2020 – Intrinsic Therapeutics hosted its first U.S. Disc Collective Meeting on 16-17 January, 2020 in Manhattan, New York. 15 spine surgeons travelled to the East Coast in order to learn more about and exchange experiences on the topic of lumbar disc herniation.  The program was themed around “A future of […]

Read more

If Barricaid is right for you, we can help.

Sign up to receive future updates and information on the Barricaid procedure.
  • This field is for validation purposes and should be left unchanged.

WordPress Lightbox Plugin